(Q35791746)

10 August 2017

1 reference

title

A chimeric live attenuated vaccine against Japanese encephalitis (English)

1 reference

Japanese encephalitis virus

10 August 2017

main subject

0 references

1 reference

1 reference

Taff Jones

1

1 reference

10 August 2017

publication date

1 June 2004

1 reference

Expert Review of Vaccines

10 August 2017

published in

1 reference

10 August 2017

volume

3

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

243-248

1 reference

Dengue and other emerging flaviviruses

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.3.243

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.3.243

Traditional and novel approaches to flavivirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.3.243

Allergic reactions to Japanese encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.3.243

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.3.243

Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.3.243

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-hu

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.3.243

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.3.243

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.3.243

Positional cloning of the murine flavivirus resistance gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.3.243

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.3.243

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.3.243

21 January 2018

Identifiers

DOI

10.1586/14760584.3.3.243

1 reference

10 August 2017

1 reference